Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
0.949
-0.019 (-1.91%)
Nov 22, 2024, 4:00 PM EST - Market closed
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $52.21 million as of November 22, 2024. Its market cap has decreased by -68.33% in one year.
Market Cap
52.21M
Enterprise Value
-83.28M
1-Year Change
-68.33%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $52.21M, a decrease of -93.53%. That is a compound annual growth rate of -48.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 52.93M | -80.24% |
| Dec 29, 2023 | 267.79M | -6.83% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | 3.03B | 276.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aileron Therapeutics | 53.51M |
| Nutriband | 53.37M |
| Elicio Therapeutics | 53.05M |
| Boundless Bio | 52.40M |
| 111, Inc. | 52.38M |
| MAIA Biotechnology | 52.10M |
| Enzo Biochem | 50.68M |
| Cytosorbents | 50.31M |